ANC 0 3 0 3 B-clinical_variable
> 4 5 4 5 O
= 5 6 5 6 O
1500 7 11 7 11 B-lower_bound
/ 11 12 11 12 I-lower_bound
mcL 12 15 12 15 I-lower_bound
( 16 17 16 17 I-lower_bound
1.5 17 20 17 20 I-lower_bound
x 21 22 21 22 I-lower_bound
0 23 24 23 24 I-lower_bound
^ 24 25 24 25 I-lower_bound
9 25 26 25 26 I-lower_bound
/ 26 27 26 27 I-lower_bound
L 27 28 27 28 I-lower_bound
) 28 29 28 29 I-lower_bound
( 30 31 30 31 O
obtained 31 39 31 39 O
within 40 46 40 46 O
2 47 48 47 48 B-upper_bound
weeks 49 54 49 54 I-upper_bound
prior 55 60 55 60 I-upper_bound
to 61 63 61 63 O
registration 64 76 64 76 O
) 76 77 76 77 O

AST 0 3 78 81 B-clinical_variable
/ 3 4 81 82 O
ALT 4 7 82 85 B-clinical_variable
= 8 9 86 87 O
< 9 10 87 88 O
2.5 11 14 89 92 B-upper_bound
x 15 16 93 94 I-upper_bound
upper 17 22 95 100 I-upper_bound
limit 23 28 101 106 I-upper_bound
of 29 31 107 109 I-upper_bound
normal 32 38 110 116 I-upper_bound
( 39 40 117 118 I-upper_bound
ULN 40 43 118 121 I-upper_bound
) 43 44 121 122 I-upper_bound
( 45 46 123 124 O
obtained 46 54 124 132 O
within 55 61 133 139 O
2 62 63 140 141 B-upper_bound
weeks 64 69 142 147 I-upper_bound
prior 70 75 148 153 I-upper_bound
to 76 78 154 156 O
registration 79 91 157 169 O
) 91 92 169 170 O

Absolute 0 8 171 179 B-clinical_variable
neutrophil 9 19 180 190 I-clinical_variable
count 20 25 191 196 I-clinical_variable
( 26 27 197 198 I-clinical_variable
ANC 27 30 198 201 I-clinical_variable
) 30 31 201 202 I-clinical_variable
> 32 33 203 204 O
= 33 34 204 205 O
1500 35 39 206 210 B-lower_bound
/ 39 40 210 211 I-lower_bound
mcL 40 43 211 214 I-lower_bound
( 44 45 215 216 I-lower_bound
1.5 45 48 216 219 I-lower_bound
x 49 50 220 221 I-lower_bound
10 51 53 222 224 I-lower_bound
^ 53 54 224 225 I-lower_bound
9 54 55 225 226 I-lower_bound
/ 55 56 226 227 I-lower_bound
L 56 57 227 228 I-lower_bound
) 57 58 228 229 I-lower_bound
( 59 60 230 231 O
obtained 60 68 231 239 O
within 69 75 240 246 O
2 76 77 247 248 B-upper_bound
weeks 78 83 249 254 I-upper_bound
prior 84 89 255 260 I-upper_bound
to 90 92 261 263 O
registration 93 105 264 276 O
) 105 106 276 277 O

All 0 3 278 281 O
prior 4 9 282 287 B-treatment
therapy 10 17 288 295 I-treatment
must 18 22 296 300 O
have 23 27 301 305 O
been 28 32 306 310 O
completed 33 42 311 320 O
at 43 45 321 323 O
least 46 51 324 329 O
21 52 54 330 332 B-upper_bound
days 55 59 333 337 I-upper_bound
prior 60 65 338 343 I-upper_bound
to 66 68 344 346 O
enrollment 69 79 347 357 O

All 0 3 358 361 O
prior 4 9 362 367 B-treatment
therapy 10 17 368 375 I-treatment
must 18 22 376 380 O
have 23 27 381 385 O
been 28 32 386 390 O
completed 33 42 391 400 O
at 43 45 401 403 O
least 46 51 404 409 O
21 52 54 410 412 B-lower_bound
days 55 59 413 417 I-lower_bound
prior 60 65 418 423 O
to 66 68 424 426 O
enrollment 69 79 427 437 O
( 80 81 438 439 O
6 81 82 439 440 O
weeks 83 88 441 446 O
for 89 92 447 450 O
nitrosoureas 93 105 451 463 O
or 106 108 464 466 O
mitomycin 109 118 467 476 B-treatment
C 119 120 477 478 I-treatment

Aspartate 0 9 479 488 B-clinical_variable
aminotransferase 10 26 489 505 I-clinical_variable
( 27 28 506 507 I-clinical_variable
AST)/alanine 28 40 507 519 I-clinical_variable
aminotransferase 41 57 520 536 I-clinical_variable
( 58 59 537 538 I-clinical_variable
ALT 59 62 538 541 I-clinical_variable
) 62 63 541 542 I-clinical_variable
= 64 65 543 544 O
< 65 66 544 545 O
2.5 67 70 546 549 B-upper_bound
x 71 72 550 551 I-upper_bound
upper 73 78 552 557 I-upper_bound
limit 79 84 558 563 I-upper_bound
of 85 87 564 566 I-upper_bound
normal 88 94 567 573 I-upper_bound
( 95 96 574 575 I-upper_bound
ULN 96 99 575 578 I-upper_bound
) 99 100 578 579 I-upper_bound
( 101 102 580 581 O
obtained 102 110 581 589 O
within 111 117 590 596 O
2 118 119 597 598 B-upper_bound
weeks 120 125 599 604 I-upper_bound
prior 126 131 605 610 I-upper_bound
to 132 134 611 613 O
registration 135 147 614 626 O
) 147 148 626 627 O

Bilirubin 0 9 628 637 B-clinical_variable
= 10 11 638 639 O
< 11 12 639 640 O
2 13 14 641 642 B-upper_bound
x 15 16 643 644 I-upper_bound
upper 17 22 645 650 I-upper_bound
limit 23 28 651 656 I-upper_bound
of 29 31 657 659 I-upper_bound
normal 32 38 660 666 I-upper_bound
( 39 40 667 668 I-upper_bound
ULN 40 43 668 671 I-upper_bound
) 43 44 671 672 I-upper_bound
( 45 46 673 674 O
unless 46 52 674 680 O
documented 53 63 681 691 O
Gilbert 64 71 692 699 B-chronic_disease
's 71 73 699 701 I-chronic_disease
syndrome 74 82 702 710 I-chronic_disease
, 82 83 710 711 O
for 84 87 712 715 O
which 88 93 716 721 O
Bilirubin 94 103 722 731 O
= 104 105 732 733 O
< 105 106 733 734 O
3 107 108 735 736 B-lower_bound
x 109 110 737 738 I-lower_bound
upper 111 116 739 744 I-lower_bound
limit 117 122 745 750 I-lower_bound
of 123 125 751 753 I-lower_bound
normal 126 132 754 760 I-lower_bound
[ 133 134 761 762 I-lower_bound
ULN 134 137 762 765 I-lower_bound
] 137 138 765 766 I-lower_bound
is 139 141 767 769 O
permitted 142 151 770 779 O
) 151 152 779 780 O
( 153 154 781 782 O
obtained 154 162 782 790 O
within 163 169 791 797 O
2 170 171 798 799 B-upper_bound
weeks 172 177 800 805 I-upper_bound
prior 178 183 806 811 I-upper_bound
to 184 186 812 814 O
registration 187 199 815 827 O
) 199 200 827 828 O

Bilirubin 0 9 829 838 B-clinical_variable
= 10 11 839 840 O
< 11 12 840 841 O
2 13 14 842 843 B-lower_bound
x 15 16 844 845 I-lower_bound
upper 17 22 846 851 I-lower_bound
limit 23 28 852 857 I-lower_bound
of 29 31 858 860 I-lower_bound
normal 32 38 861 867 I-lower_bound
( 39 40 868 869 I-lower_bound
ULN 40 43 869 872 I-lower_bound
) 43 44 872 873 I-lower_bound
( 45 46 874 875 O
unless 46 52 875 881 O
documented 53 63 882 892 O
Gilbert 64 71 893 900 B-chronic_disease
's 71 73 900 902 I-chronic_disease
syndrome 74 82 903 911 I-chronic_disease
, 82 83 911 912 O
for 84 87 913 916 O
which 88 93 917 922 O
bilirubin 94 103 923 932 B-clinical_variable
= 104 105 933 934 O
< 105 106 934 935 O
3 107 108 936 937 B-upper_bound
x 109 110 938 939 I-upper_bound
upper 111 116 940 945 I-upper_bound
limit 117 122 946 951 I-upper_bound
of 123 125 952 954 I-upper_bound
normal 126 132 955 961 I-upper_bound
[ 133 134 962 963 I-upper_bound
ULN 134 137 963 966 I-upper_bound
] 137 138 966 967 I-upper_bound
is 139 141 968 970 O
permitted 142 151 971 980 O
) 151 152 980 981 O
( 153 154 982 983 O
obtained 154 162 983 991 O
within 163 169 992 998 O
2 170 171 999 1000 B-upper_bound
weeks 172 177 1001 1006 I-upper_bound
prior 178 183 1007 1012 I-upper_bound
to 184 186 1013 1015 O
registration 187 199 1016 1028 O
) 199 200 1028 1029 O

Calculated 0 10 1030 1040 O
creatinine 11 21 1041 1051 B-clinical_variable
clearance 22 31 1052 1061 I-clinical_variable
by 32 34 1062 1064 O
Cockcroft 35 44 1065 1074 O
- 44 45 1074 1075 O
Gault 45 50 1075 1080 O
formula 51 58 1081 1088 O
> 59 60 1089 1090 O
= 60 61 1090 1091 O
30 62 64 1092 1094 B-lower_bound
ml 65 67 1095 1097 I-lower_bound
/ 67 68 1097 1098 I-lower_bound
min 68 71 1098 1101 I-lower_bound
( 72 73 1102 1103 O
obtained 73 81 1103 1111 O
within 82 88 1112 1118 O
2 89 90 1119 1120 B-upper_bound
weeks 91 96 1121 1126 I-upper_bound
prior 97 102 1127 1132 I-upper_bound
to 103 105 1133 1135 O
registration 106 118 1136 1148 O

Calculated 0 10 1149 1159 O
creatinine 11 21 1160 1170 B-clinical_variable
clearance 22 31 1171 1180 I-clinical_variable
by 32 34 1181 1183 I-clinical_variable
Cockcroft 35 44 1184 1193 I-clinical_variable
- 44 45 1193 1194 I-clinical_variable
Gault 45 50 1194 1199 I-clinical_variable
formula 51 58 1200 1207 I-clinical_variable
> 59 60 1208 1209 O
= 60 61 1209 1210 O
30 62 64 1211 1213 B-lower_bound
ml 65 67 1214 1216 I-lower_bound
/ 67 68 1216 1217 I-lower_bound
min 68 71 1217 1220 I-lower_bound
( 72 73 1221 1222 O
obtained 73 81 1222 1230 O
within 82 88 1231 1237 O
2 89 90 1238 1239 B-upper_bound
weeks 91 96 1240 1245 I-upper_bound
prior 97 102 1246 1251 I-upper_bound
to 103 105 1252 1254 O
registration 106 118 1255 1267 O
) 118 119 1267 1268 O

ECOG 0 4 1269 1273 B-clinical_variable
- 4 5 1273 1274 I-clinical_variable
ACRIN 5 10 1274 1279 I-clinical_variable
performance 11 22 1280 1291 I-clinical_variable
status 23 29 1292 1298 I-clinical_variable
between 30 37 1299 1306 O
0 38 39 1307 1308 B-lower_bound
- 39 40 1308 1309 O
2 40 41 1309 1310 B-upper_bound

Eastern 0 7 1311 1318 B-clinical_variable
Cooperative 8 19 1319 1330 I-clinical_variable
Oncology 20 28 1331 1339 I-clinical_variable
Group 29 34 1340 1345 I-clinical_variable
( 35 36 1346 1347 I-clinical_variable
ECOG)-American 36 50 1347 1361 I-clinical_variable
College 51 58 1362 1369 I-clinical_variable
of 59 61 1370 1372 I-clinical_variable
Radiology 62 71 1373 1382 I-clinical_variable
Imaging 72 79 1383 1390 I-clinical_variable
Network 80 87 1391 1398 I-clinical_variable
( 88 89 1399 1400 I-clinical_variable
ACRIN 89 94 1400 1405 I-clinical_variable
) 94 95 1405 1406 I-clinical_variable
performance 96 107 1407 1418 I-clinical_variable
status 108 114 1419 1425 I-clinical_variable
between 115 122 1426 1433 O
0 123 124 1434 1435 B-lower_bound
- 124 125 1435 1436 O
2 125 126 1436 1437 B-upper_bound

HIV 0 3 1438 1441 B-chronic_disease
viral 4 9 1442 1447 O
loads 10 15 1448 1453 O
undetectable 16 28 1454 1466 O
by 29 31 1467 1469 O
standard 32 40 1470 1478 O
clinical 41 49 1479 1487 O
HIV 50 53 1488 1491 O
testing 54 61 1492 1499 O

Long 0 4 1500 1504 O
term 5 9 1505 1509 O
survival 10 18 1510 1518 O
expected 19 27 1519 1527 O
were 28 32 1528 1532 O
it 33 35 1533 1535 O
not 36 39 1536 1539 O
for 40 43 1540 1543 O
the 44 47 1544 1547 O
cHL 48 51 1548 1551 B-cancer

No 0 2 1552 1554 O
evidence 3 11 1555 1563 O
of 12 14 1564 1566 O
prior 15 20 1567 1572 O
malignancy 21 31 1573 1583 B-cancer
except 32 38 1584 1590 O
adequately 39 49 1591 1601 O
treated 50 57 1602 1609 O
non 58 61 1610 1613 B-cancer
- 61 62 1613 1614 I-cancer
melanoma 62 70 1614 1622 I-cancer
skin 71 75 1623 1627 I-cancer
cancer 76 82 1628 1634 I-cancer
, 82 83 1634 1635 O
in 84 86 1636 1638 B-cancer
situ 87 91 1639 1643 I-cancer
cervical 92 100 1644 1652 I-cancer
carcinoma 101 110 1653 1662 I-cancer

No 0 2 1663 1665 O
evidence 3 11 1666 1674 O
of 12 14 1675 1677 O
prior 15 20 1678 1683 O
malignancy 21 31 1684 1694 B-cancer
except 32 38 1695 1701 O
adequately 39 49 1702 1712 O
treated 50 57 1713 1720 O
non 58 61 1721 1724 B-cancer
- 61 62 1724 1725 I-cancer
melanoma 62 70 1725 1733 I-cancer
skin 71 75 1734 1738 I-cancer
cancer 76 82 1739 1745 I-cancer
, 82 83 1745 1746 O
in 84 86 1747 1749 B-cancer
situ 87 91 1750 1754 I-cancer
cervical 92 100 1755 1763 I-cancer
carcinoma 101 110 1764 1773 I-cancer
or 111 113 1774 1776 O
any 114 117 1777 1780 O
surgically- 118 129 1781 1792 B-treatment
or 130 132 1793 1795 O
radiation 133 142 1796 1805 B-treatment
- 142 143 1805 1806 O
cured 143 148 1806 1811 O
malignancy 149 159 1812 1822 O
continuously 160 172 1823 1835 O
disease 173 180 1836 1843 O

No 0 2 1844 1846 O
history 3 10 1847 1854 O
of 11 13 1855 1857 O
Steven 14 20 1858 1864 B-chronic_disease
's 20 22 1864 1866 I-chronic_disease
Johnson 23 30 1867 1874 I-chronic_disease
's 30 32 1874 1876 I-chronic_disease
syndrome 33 41 1877 1885 I-chronic_disease
, 41 42 1885 1886 O
TENs 43 47 1887 1891 B-chronic_disease
syndrome 48 56 1892 1900 I-chronic_disease
, 56 57 1900 1901 O
or 58 60 1902 1904 O
motor 61 66 1905 1910 B-chronic_disease
neuropathy 67 77 1911 1921 I-chronic_disease

No 0 2 1922 1924 O
history 3 10 1925 1932 O
of 11 13 1933 1935 O
Steven 14 20 1936 1942 B-chronic_disease
's 20 22 1942 1944 I-chronic_disease
Johnson 23 30 1945 1952 I-chronic_disease
's 30 32 1952 1954 I-chronic_disease
syndrome 33 41 1955 1963 I-chronic_disease
, 41 42 1963 1964 O
toxic 43 48 1965 1970 B-chronic_disease
epidermal 49 58 1971 1980 I-chronic_disease
necrolysis 59 69 1981 1991 I-chronic_disease
( 70 71 1992 1993 I-chronic_disease
TEN)s 71 76 1993 1998 I-chronic_disease
syndrome 77 85 1999 2007 I-chronic_disease
, 85 86 2007 2008 O
or 87 89 2009 2011 O
motor 90 95 2012 2017 B-chronic_disease
neuropathy 96 106 2018 2028 I-chronic_disease

Patient 0 7 2029 2036 O
must 8 12 2037 2041 O
have 13 17 2042 2046 O
no 18 20 2047 2049 O
current 21 28 2050 2057 O
or 29 31 2058 2060 O
prior 32 37 2061 2066 O
history 38 45 2067 2074 O
of 46 48 2075 2077 O
CNS 49 52 2078 2081 B-chronic_disease
involvement 53 64 2082 2093 I-chronic_disease

Patients 0 8 2094 2102 O
may 9 12 2103 2106 O
have 13 17 2107 2111 O
received 18 26 2112 2120 O
other 27 32 2121 2126 O
prior 33 38 2127 2132 B-treatment
activating 39 49 2133 2143 I-treatment
immunotherapies 50 65 2144 2159 I-treatment
( 66 67 2160 2161 O
i.e. 67 71 2161 2165 O
checkpoint 72 82 2166 2176 B-treatment
inhibitors 83 93 2177 2187 I-treatment
) 93 94 2187 2188 O
, 94 95 2188 2189 O
but 96 99 2190 2193 O
must 100 104 2194 2198 O
not 105 108 2199 2202 O
have 109 113 2203 2207 O
received 114 122 2208 2216 O
them 123 127 2217 2221 O

Patients 0 8 2222 2230 O
may 9 12 2231 2234 O
have 13 17 2235 2239 O
received 18 26 2240 2248 O
prior 27 32 2249 2254 B-treatment
brentuximab 33 44 2255 2266 I-treatment
vedotin 45 52 2267 2274 I-treatment
, 52 53 2274 2275 O
but 54 57 2276 2279 O
must 58 62 2280 2284 O
not 63 66 2285 2288 O
have 67 71 2289 2293 O
received 72 80 2294 2302 O
brentuximab 81 92 2303 2314 O
vedotin 93 100 2315 2322 O

Patients 0 8 2323 2331 O
may 9 12 2332 2335 O
not 13 16 2336 2339 O
have 17 21 2340 2344 O
received 22 30 2345 2353 O
other 31 36 2354 2359 O
prior 37 42 2360 2365 B-treatment
activating 43 53 2366 2376 I-treatment
immunotherapies 54 69 2377 2392 I-treatment
( 70 71 2393 2394 O
i.e. 71 75 2394 2398 O
checkpoint 76 86 2399 2409 B-treatment
inhibitor 87 96 2410 2419 I-treatment
therapies 97 106 2420 2429 I-treatment
) 106 107 2429 2430 O

Patients 0 8 2431 2439 O
must 9 13 2440 2444 O
have 14 18 2445 2449 O
forced 19 25 2450 2456 B-clinical_variable
expiratory 26 36 2457 2467 I-clinical_variable
volume 37 43 2468 2474 I-clinical_variable
in 44 46 2475 2477 I-clinical_variable
1 47 48 2478 2479 I-clinical_variable
second 49 55 2480 2486 I-clinical_variable
( 56 57 2487 2488 I-clinical_variable
FEV1 57 61 2488 2492 I-clinical_variable
) 61 62 2492 2493 I-clinical_variable

Patients 0 8 2494 2502 O
must 9 13 2503 2507 O
have 14 18 2508 2512 O
no 19 21 2513 2515 O
evidence 22 30 2516 2524 O
of 31 33 2525 2527 O
dyspnea 34 41 2528 2535 B-chronic_disease
at 42 44 2536 2538 O
rest 45 49 2539 2543 O
and 50 53 2544 2547 O
a 54 55 2548 2549 O
pulse 56 61 2550 2555 B-clinical_variable
oximetry 62 70 2556 2564 I-clinical_variable
> 71 72 2565 2566 O
92 73 75 2567 2569 B-lower_bound
% 75 76 2569 2570 I-lower_bound
while 77 82 2571 2576 O
breathing 83 92 2577 2586 O
room 93 97 2587 2591 O
air 98 101 2592 2595 O

Patients 0 8 2596 2604 O
must 9 13 2605 2609 O
have 14 18 2610 2614 O
pathologically 19 33 2615 2629 O
confirmed 34 43 2630 2639 O
relapsed 44 52 2640 2648 O
or 53 55 2649 2651 O
refractory 56 66 2652 2662 O
classical 67 76 2663 2672 B-cancer
Hodgkin 77 84 2673 2680 I-cancer
lymphoma 85 93 2681 2689 I-cancer
( 94 95 2690 2691 I-cancer
cHL 95 98 2691 2694 I-cancer
) 98 99 2694 2695 I-cancer

Patients 0 8 2696 2704 O
must 9 13 2705 2709 O
have 14 18 2710 2714 O
relapsed 19 27 2715 2723 O
after 28 33 2724 2729 O
first 34 39 2730 2735 O
line 40 44 2736 2740 O
chemotherapy 45 57 2741 2753 B-treatment

Patients 0 8 2754 2762 O
must 9 13 2763 2767 O
not 14 17 2768 2771 O
be 18 20 2772 2774 O
participating 21 34 2775 2788 O
in 35 37 2789 2791 O
any 38 41 2792 2795 O
other 42 47 2796 2801 O
clinical 48 56 2802 2810 B-treatment
trial 57 62 2811 2816 I-treatment
or 63 65 2817 2819 O
taking 66 72 2820 2826 O
any 73 76 2827 2830 O
other 77 82 2831 2836 O
experimental 83 95 2837 2849 B-treatment
medications 96 107 2850 2861 I-treatment
within 108 114 2862 2868 O
21 115 117 2869 2871 B-upper_bound
days 118 122 2872 2876 I-upper_bound
prior 123 128 2877 2882 I-upper_bound
to 129 131 2883 2885 O
registration 132 144 2886 2898 O

Patients 0 8 2899 2907 O
must 9 13 2908 2912 O
not 14 17 2913 2916 O
have 18 22 2917 2921 O
New 23 26 2922 2925 B-clinical_variable
York 27 31 2926 2930 I-clinical_variable
Heart 32 37 2931 2936 I-clinical_variable
Association 38 49 2937 2948 I-clinical_variable
( 50 51 2949 2950 I-clinical_variable
NYHA 51 55 2950 2954 I-clinical_variable
) 55 56 2954 2955 I-clinical_variable
class 57 62 2956 2961 B-lower_bound
III 63 66 2962 2965 I-lower_bound
or 67 69 2966 2968 O
IV 70 72 2969 2971 B-upper_bound
heart 73 78 2972 2977 B-chronic_disease
failure 79 86 2978 2985 I-chronic_disease
, 86 87 2985 2986 O
uncontrolled 88 100 2987 2999 O
angina 101 107 3000 3006 B-chronic_disease
, 107 108 3006 3007 O
severe 109 115 3008 3014 O
uncontrolled 116 128 3015 3027 O
ventricular 129 140 3028 3039 B-chronic_disease
arrhythmias 141 152 3040 3051 I-chronic_disease
, 152 153 3051 3052 O
or 154 156 3053 3055 O
electrocardiographic 157 177 3056 3076 B-treatment
evidence 178 186 3077 3085 O
of 187 189 3086 3088 O
acute 190 195 3089 3094 O
ischemia 196 204 3095 3103 B-chronic_disease

Patients 0 8 3104 3112 O
must 9 13 3113 3117 O
not 14 17 3118 3121 O
have 18 22 3122 3126 O
a 23 24 3127 3128 O
serious 25 32 3129 3136 O
medical 33 40 3137 3144 O
or 41 43 3145 3147 O
psychiatric 44 55 3148 3159 B-chronic_disease
illness 56 63 3160 3167 I-chronic_disease
likely 64 70 3168 3174 O
to 71 73 3175 3177 O
interfere 74 83 3178 3187 O
with 84 88 3188 3192 O
study 89 94 3193 3198 O
participation 95 108 3199 3212 O

Patients 0 8 3213 3221 O
must 9 13 3222 3226 O
not 14 17 3227 3230 O
have 18 22 3231 3235 O
autoimmune 23 33 3236 3246 B-chronic_disease
disorders 34 43 3247 3256 I-chronic_disease
or 44 46 3257 3259 O
conditions 47 57 3260 3270 O
of 58 60 3271 3273 O
immunosuppression 61 78 3274 3291 B-treatment
that 79 83 3292 3296 O
require 84 91 3297 3304 O
current 92 99 3305 3312 O
ongoing 100 107 3313 3320 B-treatment
treatment 108 117 3321 3330 I-treatment
with 118 122 3331 3335 I-treatment
systemic 123 131 3336 3344 I-treatment
corticosteroids 132 147 3345 3360 I-treatment
( 148 149 3361 3362 O
or 149 151 3362 3364 O
other 152 157 3365 3370 O
systemic 158 166 3371 3379 B-treatment
immunosuppressants 167 185 3380 3398 I-treatment
) 185 186 3398 3399 O
, 186 187 3399 3400 O
including 188 197 3401 3410 O
oral 198 202 3411 3415 B-treatment
steroids 203 211 3416 3424 I-treatment
( 212 213 3425 3426 O
i.e. 213 217 3426 3430 O
, 217 218 3430 3431 O
prednisone 219 229 3432 3442 B-treatment
, 229 230 3442 3443 O
dexamethasone 231 244 3444 3457 B-treatment
) 244 245 3457 3458 O

Patients 0 8 3459 3467 O
must 9 13 3468 3472 O
not 14 17 3473 3476 O
have 18 22 3477 3481 O
grade 23 28 3482 3487 B-lower_bound
2 29 30 3488 3489 I-lower_bound
or 31 33 3490 3492 O
greater 34 41 3493 3500 O
peripheral 42 52 3501 3511 O
sensory 53 60 3512 3519 O
n 61 62 3520 3521 O

Patients 0 8 3522 3530 O
must 9 13 3531 3535 O
not 14 17 3536 3539 O
have 18 22 3540 3544 O
grade 23 28 3545 3550 B-lower_bound
2 29 30 3551 3552 I-lower_bound
or 31 33 3553 3555 O
greater 34 41 3556 3563 O
peripheral 42 52 3564 3574 B-clinical_variable
sensory 53 60 3575 3582 I-clinical_variable
neuropathy 61 71 3583 3593 I-clinical_variable

Patients 0 8 3594 3602 O
must 9 13 3603 3607 O
not 14 17 3608 3611 O
have 18 22 3612 3616 O
previously 23 33 3617 3627 O
existing 34 42 3628 3636 O
hypersensitivity 43 59 3637 3653 O
to 60 62 3654 3656 O
brentuximab 63 74 3657 3668 B-allergy_name
vedotin 75 82 3669 3676 I-allergy_name
or 83 85 3677 3679 O
ipilimumab 86 96 3680 3690 B-allergy_name

Platelets 0 9 3691 3700 B-clinical_variable
> 10 11 3701 3702 O
= 11 12 3702 3703 O
75,000 13 19 3704 3710 B-lower_bound
/ 19 20 3710 3711 I-lower_bound
mcL 20 23 3711 3714 I-lower_bound
( 24 25 3715 3716 I-lower_bound
75 25 27 3716 3718 I-lower_bound
x 28 29 3719 3720 I-lower_bound
10 30 32 3721 3723 I-lower_bound
^ 32 33 3723 3724 I-lower_bound
9 33 34 3724 3725 I-lower_bound
/ 34 35 3725 3726 I-lower_bound
L 35 36 3726 3727 I-lower_bound
) 36 37 3727 3728 I-lower_bound
( 38 39 3729 3730 O
obtained 39 47 3730 3738 O
within 48 54 3739 3745 O
2 55 56 3746 3747 B-upper_bound
weeks 57 62 3748 3753 I-upper_bound
prior 63 68 3754 3759 I-upper_bound
to 69 71 3760 3762 O
registration 72 84 3763 3775 O
) 84 85 3775 3776 O

Replacement 0 11 3777 3788 O
doses 12 17 3789 3794 O
of 18 20 3795 3797 O
steroids 21 29 3798 3806 B-treatment
for 30 33 3807 3810 O
patients 34 42 3811 3819 O
with 43 47 3820 3824 O
adrenal 48 55 3825 3832 B-chronic_disease
insufficiency 56 69 3833 3846 I-chronic_disease
are 70 73 3847 3850 O
allowed 74 81 3851 3858 O

Routine 0 7 3859 3866 B-treatment
vaccinations 8 20 3867 3879 I-treatment
, 20 21 3879 3880 O
including 22 31 3881 3890 O
seasonal 32 40 3891 3899 B-chronic_disease
influenza 41 50 3900 3909 I-chronic_disease
, 50 51 3909 3910 O
should 52 58 3911 3917 O
be 59 61 3918 3920 O
given 62 67 3921 3926 O
at 68 70 3927 3929 O
least 71 76 3930 3935 O
2 77 78 3936 3937 B-lower_bound
weeks 79 84 3938 3943 I-lower_bound
prior 85 90 3944 3949 I-lower_bound
to 91 93 3950 3952 O
study 94 99 3953 3958 O
treatment 100 109 3959 3968 O

Willing 0 7 3969 3976 O
to 8 10 3977 3979 O
adhere 11 17 3980 3986 O
to 18 20 3987 3989 O
effective 21 30 3990 3999 O
combination 31 42 4000 4011 O
antiretroviral 43 57 4012 4026 B-treatment
therapy 58 65 4027 4034 I-treatment

Women 0 5 4035 4040 B-gender
must 6 10 4041 4045 O
not 11 14 4046 4049 O
be 15 17 4050 4052 O
pregnant 18 26 4053 4061 B-pregnancy
or 27 29 4062 4064 O
breast 30 36 4065 4071 O
- 36 37 4071 4072 O
feeding 37 44 4072 4079 O
due 45 48 4080 4083 O
to 49 51 4084 4086 O
risk 52 56 4087 4091 O
of 57 59 4092 4094 O
fetal 60 65 4095 4100 O
harm 66 70 4101 4105 O
by 71 73 4106 4108 O
the 74 77 4109 4112 O
chemotherapeutic 78 94 4113 4129 B-treatment
agents 95 101 4130 4136 I-treatment
prescribed 102 112 4137 4147 O
in 113 115 4148 4150 O
this 116 120 4151 4155 O
protocol 121 129 4156 4164 O

Women 0 5 4165 4170 B-gender
of 6 8 4171 4173 O
childbearing 9 21 4174 4186 O
potential 22 31 4187 4196 O
( 32 33 4197 4198 O
WOCBP 33 38 4198 4203 O
) 38 39 4203 4204 O

a 0 1 4205 4206 O
female 2 8 4207 4213 B-gender
of 9 11 4214 4216 O
childbearing 12 24 4217 4229 O
potential 25 34 4230 4239 O
is 35 37 4240 4242 O
any 38 41 4243 4246 O
woman 42 47 4247 4252 B-gender
, 47 48 4252 4253 O
regardless 49 59 4254 4264 O
of 60 62 4265 4267 O
sexual 63 69 4268 4274 O
orientation 70 81 4275 4286 O
or 82 84 4287 4289 O
whether 85 92 4290 4297 O
they 93 97 4298 4302 O
have 98 102 4303 4307 O
undergone 103 112 4308 4317 O
tubal 113 118 4318 4323 B-treatment
ligation 119 127 4324 4332 I-treatment

a 0 1 4333 4334 O
history 2 9 4335 4342 O
of 10 12 4343 4345 O
occasional 13 23 4346 4356 O
( 24 25 4357 4358 O
but 25 28 4358 4361 O
not 29 32 4362 4365 O
continuous 33 43 4366 4376 O
) 43 44 4376 4377 O
use 45 48 4378 4381 O
of 49 51 4382 4384 O
steroid 52 59 4385 4392 B-treatment
inhalers 60 68 4393 4401 O
is 69 71 4402 4404 O
allowed 72 79 4405 4412 O

abnormal 0 8 4413 4421 O
PET 9 12 4422 4425 B-treatment
scans 13 18 4426 4431 I-treatment
will 19 23 4432 4436 O
not 24 27 4437 4440 O
constitute 28 38 4441 4451 O
evaluable 39 48 4452 4461 O
disease 49 56 4462 4469 O
unless 57 63 4470 4476 O
verified 64 72 4477 4485 O
by 73 75 4486 4488 O
a 76 77 4489 4490 O
diagnostic 78 88 4491 4501 O
quality 89 96 4502 4509 O
CT 97 99 4510 4512 B-treatment
scan 100 104 4513 4517 I-treatment

abnormal 0 8 4518 4526 O
positron 9 17 4527 4535 B-treatment
emission 18 26 4536 4544 I-treatment
tomography 27 37 4545 4555 I-treatment
( 38 39 4556 4557 I-treatment
PET 39 42 4557 4560 I-treatment
) 42 43 4560 4561 I-treatment
scans 44 49 4562 4567 I-treatment
will 50 54 4568 4572 O
not 55 58 4573 4576 O
constitute 59 69 4577 4587 O
evaluable 70 79 4588 4597 O
disease 80 87 4598 4605 O
unless 88 94 4606 4612 O
verified 95 103 4613 4621 O
by 104 106 4622 4624 O
a 107 108 4625 4626 O
diagnostic 109 119 4627 4637 O
quality 120 127 4638 4645 O
computed 128 136 4646 4654 B-treatment
tomography 137 147 4655 4665 I-treatment
( 148 149 4666 4667 I-treatment
CT 149 151 4667 4669 I-treatment
) 151 152 4669 4670 I-treatment
scan 153 157 4671 4675 I-treatment

agree 0 5 4676 4681 B-contraception_consent
to 6 8 4682 4684 I-contraception_consent
use 9 12 4685 4688 I-contraception_consent
both 13 17 4689 4693 I-contraception_consent
single 18 24 4694 4700 I-contraception_consent
barrier 25 32 4701 4708 I-contraception_consent
contraception 33 46 4709 4722 I-contraception_consent
and 47 50 4723 4726 I-contraception_consent
birth 51 56 4727 4732 I-contraception_consent
control 57 64 4733 4740 I-contraception_consent
pills 65 70 4741 4746 I-contraception_consent

all 0 3 4747 4750 O
females 4 11 4751 4758 B-gender
of 12 14 4759 4761 O
childbearing 15 27 4762 4774 O
potential 28 37 4775 4784 O
must 38 42 4785 4789 O
have 43 47 4790 4794 O
a 48 49 4795 4796 O
blood 50 55 4797 4802 O
test 56 60 4803 4807 O
or 61 63 4808 4810 O
urine 64 69 4811 4816 O
study 70 75 4817 4822 O

all 0 3 4823 4826 B-gender
females 4 11 4827 4834 I-gender
of 12 14 4835 4837 O
childbearing 15 27 4838 4850 O
potential 28 37 4851 4860 O
must 38 42 4861 4865 O
have 43 47 4866 4870 O
a 48 49 4871 4872 O
blood 50 55 4873 4878 B-treatment
test 56 60 4879 4883 I-treatment
or 61 63 4884 4886 O
urine 64 69 4887 4892 O
study 70 75 4893 4898 O
within 76 82 4899 4905 O
24 83 85 4906 4908 B-upper_bound
hours 86 91 4909 4914 I-upper_bound
prior 92 97 4915 4920 I-upper_bound
to 98 100 4921 4923 O
enrollment 101 111 4924 4934 O
to 112 114 4935 4937 O
rule 115 119 4938 4942 O
out 120 123 4943 4946 O
pregnancy 124 133 4947 4956 B-pregnancy

all 0 3 4957 4960 O
pulmonary 4 13 4961 4970 O
function 14 22 4971 4979 O
tests 23 28 4980 4985 O
must 29 33 4986 4990 O
be 34 36 4991 4993 O
obtained 37 45 4994 5002 O
within 46 52 5003 5009 O
one 53 56 5010 5013 B-upper_bound
month 57 62 5014 5019 I-upper_bound
prior 63 68 5020 5025 I-upper_bound
to 69 71 5026 5028 O
registration 72 84 5029 5041 O

any 0 3 5042 5045 O
surgically- 4 15 5046 5057 O
or 16 18 5058 5060 O
radiation 19 28 5061 5070 B-treatment
- 28 29 5070 5071 O
cured 29 34 5071 5076 O
malignancy 35 45 5077 5087 B-cancer
continuously 46 58 5088 5100 O
disease 59 66 5101 5108 O
free 67 71 5109 5113 O
for 72 75 5114 5117 O
> 76 77 5118 5119 O
= 77 78 5119 5120 O
5 79 80 5121 5122 B-lower_bound
years 81 86 5123 5128 I-lower_bound
so 87 89 5129 5131 O
as 90 92 5132 5134 O
not 93 96 5135 5138 O
to 97 99 5139 5141 O
interfere 100 109 5142 5151 O
with 110 114 5152 5156 O
interpretation 115 129 5157 5171 O
of 130 132 5172 5174 O
radiographic 133 145 5175 5187 O
response 146 154 5188 5196 O

are 0 3 5197 5200 O
on 4 6 5201 5203 O
a 7 8 5204 5205 O
stable 9 15 5206 5212 O
antiviral 16 25 5213 5222 B-treatment
regimen 26 33 5223 5230 I-treatment
; 33 34 5230 5231 O
patients 35 43 5232 5240 O
with 44 48 5241 5245 O
poorly 49 55 5246 5252 O
controlled 56 66 5253 5263 O
HIV 67 70 5264 5267 B-chronic_disease
or 71 73 5268 5270 O
other 74 79 5271 5276 O
chronic 80 87 5277 5284 O
active 88 94 5285 5291 B-chronic_disease
viral 95 100 5292 5297 I-chronic_disease
infections 101 111 5298 5308 I-chronic_disease
will 112 116 5309 5313 O
be 117 119 5314 5316 O
excluded 120 128 5317 5325 O

continuing 0 10 5326 5336 O
for 11 14 5337 5340 O
5 15 16 5341 5342 B-upper_bound
months 17 23 5343 5349 I-upper_bound
after 24 29 5350 5355 I-upper_bound
the 30 33 5356 5359 O
last 34 38 5360 5364 O
dose 39 43 5365 5369 O
of 44 46 5370 5372 O
study 47 52 5373 5378 B-treatment
drug 53 57 5379 5383 I-treatment
( 58 59 5384 5385 O
for 59 62 5385 5388 O
female 63 69 5389 5395 B-gender
patients 70 78 5396 5404 I-gender
) 78 79 5404 5405 O
and 80 83 5406 5409 O
for 84 87 5410 5413 O
7 88 89 5414 5415 B-upper_bound
months 90 96 5416 5422 I-upper_bound
after 97 102 5423 5428 I-upper_bound
the 103 106 5429 5432 O
last 107 111 5433 5437 O
dose 112 116 5438 5442 O
of 117 119 5443 5445 O
study 120 125 5446 5451 O
drug 126 130 5452 5456 O
( 131 132 5457 5458 O
for 132 135 5458 5461 O
male 136 140 5462 5466 O
patients 141 149 5467 5475 O
who 150 153 5476 5479 O
are 154 157 5480 5483 O
sexually 158 166 5484 5492 O
active 167 173 5493 5499 O
with 174 178 5500 5504 O
WOCBP 179 184 5505 5510 O
) 184 185 5510 5511 O

continuous 0 10 5512 5522 O
use 11 14 5523 5526 O
of 15 17 5527 5529 O
topical 18 25 5530 5537 B-treatment
steroid 26 33 5538 5545 I-treatment
creams 34 40 5546 5552 I-treatment
or 41 43 5553 5555 O
ointments 44 53 5556 5565 B-treatment
or 54 56 5566 5568 O
ophthalmologic 57 71 5569 5583 O
steroids 72 80 5584 5592 I-treatment

for 0 3 5593 5596 O
the 4 7 5597 5600 O
purposes 8 16 5601 5609 O
of 17 19 5610 5612 O
this 20 24 5613 5617 O
study 25 30 5618 5623 O
monoclonal 31 41 5624 5634 O
antibodies 42 52 5635 5645 O
and 53 56 5646 5649 O
antibody 57 65 5650 5658 B-treatment
drug 66 70 5659 5663 I-treatment
conjugates 71 81 5664 5674 I-treatment
are 82 85 5675 5678 O
not 86 89 5679 5682 O
considered 90 100 5683 5693 O
to 101 103 5694 5696 O
be 104 106 5697 5699 O
activating 107 117 5700 5710 O
immunotherapies 118 133 5711 5726 B-treatment
and 134 137 5727 5730 O
there 138 143 5731 5736 O
are 144 147 5737 5740 O
no 148 150 5741 5743 O
additional 151 161 5744 5754 O
time 162 166 5755 5759 O
restrictions 167 179 5760 5772 O
on 180 182 5773 5775 O
prior 183 188 5776 5781 O
exposure 189 197 5782 5790 O
to 198 200 5791 5793 O
these 201 206 5794 5799 O
agents 207 213 5800 5806 O
( 214 215 5807 5808 O
except 215 221 5808 5814 O
prior 222 227 5815 5820 O
brentuximab 228 239 5821 5832 B-treatment
vedotin 240 247 5833 5840 I-treatment
) 247 248 5840 5841 O

free 0 4 5842 5846 O
for 5 8 5847 5850 O
> 9 10 5851 5852 O
= 10 11 5852 5853 O
5 12 13 5854 5855 B-lower_bound
years 14 19 5856 5861 I-lower_bound
so 20 22 5862 5864 O
as 23 25 5865 5867 O
not 26 29 5868 5871 O
to 30 32 5872 5874 O
interfere 33 42 5875 5884 O
with 43 47 5885 5889 O
interpretation 48 62 5890 5904 O
of 63 65 5905 5907 O
radiographic 66 78 5908 5920 O
response 79 87 5921 5929 O

has 0 3 5930 5933 O
had 4 7 5934 5937 O
menses 8 14 5938 5944 O
at 15 17 5945 5947 O
any 18 21 5948 5951 O
time 22 26 5952 5956 O
in 27 29 5957 5959 O
the 30 33 5960 5963 O
preceding 34 43 5964 5973 B-upper_bound
24 44 46 5974 5976 I-upper_bound
consecutive 47 58 5977 5988 I-upper_bound
months 59 65 5989 5995 I-upper_bound

has 0 3 5996 5999 O
not 4 7 6000 6003 O
been 8 12 6004 6008 O
naturally 13 22 6009 6018 O
postmenopausal 23 37 6019 6033 O
for 38 41 6034 6037 O
at 42 44 6038 6040 O
least 45 50 6041 6046 O
24 51 53 6047 6049 B-lower_bound
consecutive 54 65 6050 6061 I-lower_bound
months 66 72 6062 6068 I-lower_bound

has 0 3 6069 6072 O
not 4 7 6073 6076 O
been 8 12 6077 6081 O
naturally 13 22 6082 6091 O
postmenopausal 23 37 6092 6106 O
for 38 41 6107 6110 O
at 42 44 6111 6113 O
least 45 50 6114 6119 O
24 51 53 6120 6122 B-lower_bound
consecutive 54 65 6123 6134 I-lower_bound
months 66 72 6135 6141 I-lower_bound
( 73 74 6142 6143 O
i.e. 74 78 6143 6147 O
, 78 79 6147 6148 O
has 80 83 6149 6152 O
had 84 87 6153 6156 O
menses 88 94 6157 6163 O
at 95 97 6164 6166 O
any 98 101 6167 6170 O
time 102 106 6171 6175 O
in 107 109 6176 6178 O
the 110 113 6179 6182 O
preceding 114 123 6183 6192 B-upper_bound
24 124 126 6193 6195 I-upper_bound
consecutive 127 138 6196 6207 I-upper_bound
months 139 145 6208 6214 I-upper_bound
) 145 146 6214 6215 O

has 0 3 6216 6219 O
not 4 7 6220 6223 O
undergone 8 17 6224 6233 O
a 18 19 6234 6235 O
hysterectomy 20 32 6236 6248 B-treatment
or 33 35 6249 6251 O
bilateral 36 45 6252 6261 B-treatment
oophorectomy 46 58 6262 6274 I-treatment

have 0 4 6275 6279 O
primary 5 12 6280 6287 B-chronic_disease
refractory 13 23 6288 6298 I-chronic_disease
disease 24 31 6299 6306 I-chronic_disease

implants 0 8 6307 6315 B-treatment
for 9 12 6316 6319 O
at 13 15 6320 6322 O
least 16 21 6323 6328 O
one 22 25 6329 6332 B-lower_bound
week 26 30 6333 6337 I-lower_bound
prior 31 36 6338 6343 I-lower_bound
to 37 39 6344 6346 O
the 40 43 6347 6350 O
start 44 49 6351 6356 O
of 50 52 6357 6359 O
the 53 56 6360 6363 O
study 57 62 6364 6369 B-treatment
drug 63 67 6370 6374 I-treatment

may 0 3 6375 6378 O
have 4 8 6379 6383 O
relapsed 9 17 6384 6392 O
after 18 23 6393 6398 O
autologous 24 34 6399 6409 B-treatment
or 35 37 6410 6412 O
allogeneic 38 48 6413 6423 B-treatment
stem 49 53 6424 6428 I-treatment
cell 54 58 6429 6433 I-treatment
transplant 59 69 6434 6444 I-treatment

must 0 4 6445 6449 O
be 5 7 6450 6452 O
no 8 10 6453 6455 O
serious 11 18 6456 6463 O
unresolved 19 29 6464 6474 O
complication 30 42 6475 6487 O
of 43 45 6488 6490 O
therapy 46 53 6491 6498 B-treatment
at 54 56 6499 6501 O
the 57 60 6502 6505 O
time 61 65 6506 6510 O
of 66 68 6511 6513 O
registration 69 81 6514 6526 O

must 0 4 6527 6531 O
not 5 8 6532 6535 O
currently 9 18 6536 6545 O
be 19 21 6546 6548 O
smoking 22 29 6549 6556 O
tobacco 30 37 6557 6564 O
or 38 40 6565 6567 O
other 41 46 6568 6573 O
substances 47 57 6574 6584 O
and 58 61 6585 6588 O
must 62 66 6589 6593 O
not 67 70 6594 6597 O
have 71 75 6598 6602 O
smoked 76 82 6603 6609 O
within 83 89 6610 6616 O
the 90 93 6617 6620 O
past 94 98 6621 6625 B-upper_bound
6 99 100 6626 6627 I-upper_bound
months 101 107 6628 6634 I-upper_bound

must 0 4 6635 6639 O
not 5 8 6640 6643 O
have 9 13 6644 6648 O
relapsed 14 22 6649 6657 O
within 23 29 6658 6664 O
6 30 31 6665 6666 B-upper_bound
months 32 38 6667 6673 I-upper_bound
of 39 41 6674 6676 O
receiving 42 51 6677 6686 O
previous 52 60 6687 6695 O
brentuximab 61 72 6696 6707 B-treatment
vedotin 73 80 6708 6715 I-treatment

no 0 2 6716 6718 O
upper 3 8 6719 6724 O
limit 9 14 6725 6730 O
for 15 18 6731 6734 O
number 19 25 6735 6741 O
of 26 28 6742 6744 O
prior 29 34 6745 6750 B-treatment
therapies 35 44 6751 6760 I-treatment

other 0 5 6761 6766 O
histologies 6 17 6767 6778 O
including 18 27 6779 6788 O
lymphocyte 28 38 6789 6799 B-cancer
predominant 39 50 6800 6811 I-cancer
( 51 52 6812 6813 I-cancer
LP 52 54 6813 6815 I-cancer
) 54 55 6815 6816 I-cancer
HL 56 58 6817 6819 I-cancer
are 59 62 6820 6823 O
not 63 66 6824 6827 O
permitted 67 76 6828 6837 O

patients 0 8 6838 6846 O
in 9 11 6847 6849 O
the 12 15 6850 6853 O
nivolumab 16 25 6854 6863 B-treatment
/ 25 26 6863 6864 O
brentuximab 26 37 6864 6875 B-treatment
cohorts 38 45 6876 6883 O
ONLY 46 50 6884 6888 O
( 51 52 6889 6890 O
D 52 53 6890 6891 O
, 53 54 6891 6892 O
E 55 56 6893 6894 O
, 56 57 6894 6895 O
F 58 59 6896 6897 O
, 59 60 6897 6898 O
Y 61 62 6899 6900 O
) 62 63 6900 6901 O
may 64 67 6902 6905 O
have 68 72 6906 6910 O
received 73 81 6911 6919 O
prior 82 87 6920 6925 B-treatment
ipilimumab 88 98 6926 6936 I-treatment

patients 0 8 6937 6945 O
may 9 12 6946 6949 O
not 13 16 6950 6953 O
have 17 21 6954 6958 O
received 22 30 6959 6967 O
prior 31 36 6968 6973 B-treatment
ipilimumab 37 47 6974 6984 I-treatment

patients 0 8 6985 6993 O
may 9 12 6994 6997 O
not 13 16 6998 7001 O
have 17 21 7002 7006 O
received 22 30 7007 7015 O
prior 31 36 7016 7021 B-treatment
nivolumab 37 46 7022 7031 I-treatment
or 47 49 7032 7034 O
PD1 50 53 7035 7038 B-treatment
/ 53 54 7038 7039 O
PDL1 54 58 7039 7043 B-treatment
axis 59 63 7044 7048 I-treatment
agents 64 70 7049 7055 I-treatment

patients 0 8 7056 7064 O
must 9 13 7065 7069 O
use 14 17 7070 7073 O
the 18 21 7074 7077 O
same 22 26 7078 7082 O
imaging 27 34 7083 7090 O
modality 35 43 7091 7099 O
( 44 45 7100 7101 O
CT 45 47 7101 7103 B-treatment
or 48 50 7104 7106 O
PET 51 54 7107 7110 B-treatment
/ 54 55 7110 7111 I-treatment
CT 55 57 7111 7113 I-treatment
) 57 58 7113 7114 O
throughout 59 69 7115 7125 O
the 70 73 7126 7129 O
study 74 79 7130 7135 O

sexually 0 8 7136 7144 O
active 9 15 7145 7151 O
males 16 21 7152 7157 B-gender
must 22 26 7158 7162 O
either 27 33 7163 7169 O
abstain 34 41 7170 7177 O
from 42 46 7178 7182 O
sexual 47 53 7183 7189 O
intercourse 54 65 7190 7201 O
for 66 69 7202 7205 O
the 70 73 7206 7209 O
duration 74 82 7210 7218 O
of 83 85 7219 7221 O
their 86 91 7222 7227 O
participation 92 105 7228 7241 O
in 106 108 7242 7244 O
the 109 112 7245 7248 O
study 113 118 7249 7254 O

should 0 6 7255 7261 O
a 7 8 7262 7263 O
woman 9 14 7264 7269 B-gender
become 15 21 7270 7276 B-pregnancy
pregnant 22 30 7277 7285 I-pregnancy
or 31 33 7286 7288 O
suspect 34 41 7289 7296 O
she 42 45 7297 7300 O
is 46 48 7301 7303 B-pregnancy
pregnant 49 57 7304 7312 I-pregnancy
while 58 63 7313 7318 O
she 64 67 7319 7322 O
or 68 70 7323 7325 O
her 71 74 7326 7329 O
partner 75 82 7330 7337 O
is 83 85 7338 7340 O
participating 86 99 7341 7354 O
in 100 102 7355 7357 O
this 103 107 7358 7362 O
study 108 113 7363 7368 O

vaccines 0 8 7369 7377 O
are 9 12 7378 7381 O
not 13 16 7382 7385 O
prohibited 17 27 7386 7396 O
on 28 30 7397 7399 O
study 31 36 7400 7405 O
, 36 37 7405 7406 O
but 38 41 7407 7410 O
must 42 46 7411 7415 O
be 47 49 7416 7418 O
given 50 55 7419 7424 O
at 56 58 7425 7427 O
least 59 64 7428 7433 O
6 65 66 7434 7435 B-lower_bound
weeks 67 72 7436 7441 I-lower_bound
after 73 78 7442 7447 O
cycle 79 84 7448 7453 O
1 85 86 7454 7455 O
and 87 90 7456 7459 O
not 91 94 7460 7463 O
within 95 101 7464 7470 O
7 102 103 7471 7472 B-lower_bound
days 104 108 7473 7477 I-lower_bound
of 109 111 7478 7480 O
treatment 112 121 7481 7490 B-treatment

within 0 6 7491 7497 O
2 7 8 7498 7499 B-upper_bound
weeks 9 14 7500 7505 I-upper_bound
prior 15 20 7506 7511 I-upper_bound
to 21 23 7512 7514 O
registration 24 36 7515 7527 O
to 37 39 7528 7530 O
rule 40 44 7531 7535 O
out 45 48 7536 7539 O
pregnancy 49 58 7540 7549 B-pregnancy

within 0 6 7550 7556 O
4 7 8 7557 7558 B-upper_bound
weeks 9 14 7559 7564 I-upper_bound
of 15 17 7565 7567 O
registration 18 30 7568 7580 O
to 31 33 7581 7583 O
the 34 37 7584 7587 O
study 38 43 7588 7593 O

within 0 6 7594 7600 O
6 7 8 7601 7602 B-upper_bound
months 9 15 7603 7609 I-upper_bound
prior 16 21 7610 7615 I-upper_bound
to 22 24 7616 7618 O
registration 25 37 7619 7631 O

